Latest articles for Major Depressive Disorder
Conference Coverage
New data on IV ketamine for resistant depression in the elderly
Overall, 48% of participants achieved a response, and 24% achieved remission of depressive symptoms following the first 4 weeks of twice-weekly...
Conference Coverage
Add-on antipsychotic beats switching meds in older adults with resistant depression
“These results are of great impact for clinicians managing older adults with treatment-resistant depression,” said Dr. Jennifer Gatchel.
From the Journals
Modified ECT lowers dental, skeletal fracture risk
Clinicians who provide ECT “need to be aware of rare adverse effects, as well as the common ones,” said Dr. Chittaranjan Andrade.
From the Journals
Distinct suicidal thought patterns flag those at highest risk
New research indicates that ideation and cognition “may act as independent risk factors for suicidal behavior.”
From the Journals
Thyroid hormones predict psychotic depression in MDD patients
Regular thyroid function tests may help with early identification and intervention of PD.
From the Journals
Beyond the psychedelic effect: Ayahuasca as antidepressant
Some acute measures assessed during ayahuasca dosing moderated the improvements in MDD biomarkers 2 days after a treatment session.
From the Journals
Statin disappoints for treatment-resistant depression
“Clinical trials of other statins ... have also been congruent with our results,” said Dr. M. Ishrat Husain.
From the Journals
Repetitive TMS effective for comorbid depression, substance use
“I suspect this is just the beginning of a new era in neuromodulation-based therapeutics for people struggling with drug and alcohol use disorders...
From the Journals
Bright light therapy boosts therapeutic response
Patients who were resistant to other treatment showed benefits after bright light therapy.
Latest News
Mental health system failing kids leaving ED
Fewer than one-third had an outpatient visit within a week. Editorialists call for a “child mental health moonshot.”